September 20, 2017

Selexis SA, Spinomix SA and the University of Lausanne Publish Novel, High-Throughput Technology Process for Isolation of High Secretion CHO Cell Clones

Read More
September 05, 2017

Selexis to Participate at Several Upcoming Industry Conferences

Read More
June 27, 2017

Selexis Announces Commercial License Agreement with Takeda for the Development of Fusion Proteins

Read More
June 14, 2017

JSR Life Sciences Agrees to Acquire Pioneering Cell Line Developer Selexis SA and Integrate Selexis with KBI Biopharma, Inc.

Read More
June 12, 2017

Selexis SA and TeneoBio, Inc. Team Up to Advance the Development of UniAbs Targeting Cancer

Read More